Skip to main content
OpenTrials
Completed

NCT Number: NCT03874988

Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+

This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies (prepackaged/portion-controlled meals; enhanced self-monitoring; the GLB-SCI) to inform design of an empirically supported and consumer-validated multicomponent intervention program, that combines the best of the 3 approaches into one unique intervention, the GLB SCI+. Based on the investigators' prior experience with adapting and delivering the GLB AIM (a lifestyle intervention previously adapted for those with impaired mobility), interim findings, existing literature, and consumer feedback, they hypothesize that these 3 unique strategies may confer individualized benefits to people with SCI given their complex disability-related barriers to weight loss.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Baylor Scott & White Institute for Rehabilitation - Dallas

Dallas, Texas, 75246, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over 18 years old
  • Have had a spinal cord injury for at least 1 year
  • Overweight as evidenced by BMI > 25
  • Must have sufficient upper arm mobility to engage in exercise
  • Must have access to the internet
  • Must be able to obtain physician signed clearance to participate in a weight management intervention

Exclusion criteria

  • Cognitive impairment which substantially impairs autonomy (e.g. mental retardation)
  • Medical issues for which exercise is contraindicated such as uncontrolled hypertension or coronary heart disease,
  • Pregnancy
  • Not fluent in English
  • Presence of grade 3 or 4 pressure ulcer
  • Previously diagnosed eating disorder

Treatment and study plan

Portion-Controlled Meals

Behavioral

Participants will receive portion-controlled meals with the aim of encouraging weight loss and healthier eating.

Enhanced Self-Monitoring

Behavioral

Participants will be encouraged to track their physical activity, food intake, and weight using technology that will be provided as part of the study.

GLB-SCI

Behavioral

Participants will take part in a lifestyle intervention program (tailored for spinal cord injury needs) that encourages steady weight loss through increased physical activity and healthier diet patterns.

GLB-SCI+

Behavioral

Participants will receive a combination of the prior interventions studied, with the goal of showing that a multi-component intervention will be the most effective in encouraging weight loss among participants with a spinal cord injury.

Primary outcomes

  1. Change in weight

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Change in weight (pounds) will be measured after each 13-week intervention.

  2. Change in physical activity level

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Change in self-reported physical activity (minutes per week) will be measured after each 13-week intervention to assess whether the intervention effectively encouraged greater levels of physical activity.

  3. Self-efficacy

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Self-efficacy will be measured through changes in the Self-Rated Abilities for Health Practices Scale from baseline to post-intervention. The questionnaire contains 28 items that are on a 5-point scale. It was designed to measure a person's perception of his/her own ability to practice "healthy" behaviors and has 4 sub-scales with 7 items each: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being. Ratings for each subscale are summed to yield subscale scores and subscale scores are summed to obtain a total score. Higher scores indicate greater confidence in one's ability to perform health practices and total scores range from 0-112.

  4. Function/Quality of Life

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Changes in self-reported levels of function and quality of life will be assessed through the LIFE-H survey, given before and after each intervention. The Assessment of Life Habits (LIFE-H) assesses a person's self-reported difficulty with and need for assistance performing tasks associated with activities of daily living (ADL) and social roles. The version used for this study covers 6 ADL categories: nutrition, fitness, personal care, communication, residence, mobility and 6 social role categories: responsibility, interpersonal relations, community, education, employment, recreation. Scoring is based on respondent rating of level of accomplishment (No difficulty to Not accomplished) combined with the type of assistance (if any) used to perform these tasks. Scores range from 9 to 0, with higher scores indicating less difficulty.

Secondary outcomes

  1. Change in waist circumference

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Participants will have their waist circumference measured before and after each intervention to assess the level of change, if any.

  2. Change in blood pressure (systolic and diastolic)

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Participants will have their blood pressure measured before and after each intervention to assess the level of change, if any.

  3. Change in hemoglobin A1c level

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Participants will have their hemoglobin A1c measured before and after each intervention assess the level of change, if any.

  4. Change in motivation for weight-loss

    Time frame: Approximately every 13 weeks through study completion, expected to be 3 years.

    Participants will have their levels of motivation assessed before and after each intervention with the Treatment Self-Regulation Questionnaire. The 18-item Treatment Self-Regulation Questionnaire is derived from self-determination theory and yields 2 subscales: autonomous regulation (or intrinsic motivation) and controlled regulation (or extrinsic motivation). Responses are provided on a 7-point Likert type scale ranging from 1 'not at all true' to 7 'very true,' and includes the option of "not applicable." Autonomous Regulation scores are obtained by averaging questions 3, 4, 9, 13, 17, 18 and Controlled Regulation scores are obtained by averaging questions 1, 2, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16. Higher scores indicate higher levels of motivation. Higher scores indicate higher levels of each type of regulation.

Other outcomes

  1. Group meeting attendance

    Time frame: Attendance will be tracked over the entire 13-week intervention.

    Intervention arms involving meeting on a regular basis will have attendance tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.

  2. Adherence to self-monitoring

    Time frame: Adherence will be tracked over the entire 13-week intervention.

    Intervention arms involving self-monitoring food intake and physical activity will have levels of adherence tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.

  3. Individualized teleconference attendance

    Time frame: Attendance will be tracked over the entire 13-week intervention.

    Intervention arms involving teleconference meeting attendance will have levels of adherence tracked to examine correlations between attendance and weight-loss.

  4. Participant perceptions of each intervention

    Time frame: Perception will be assessed at the end of the 13-week intervention.

    Participant perceptions will be assessed using a survey that asks participants to rate on a scale of 1 - 5 each active component used in each study

Sponsors and collaborators

Lead sponsor

Baylor Research Institute

Other

Registry information

Acronym: GLB-SCI+

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Mar 14, 2019
Registry last updated
Oct 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.